Rosacea Stocks List

Rosacea Stocks Recent News

Date Stock Title
May 10 TARS Tarsus Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
May 9 TARS Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference
May 9 TARS Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q1 2024 Earnings Call Transcript
May 9 VYNE VYNE Therapeutics GAAP EPS of -$0.15 beats by $0.09, revenue of $0.01M misses by $0.09M
May 9 TARS Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2
May 9 VYNE VYNE Reports First Quarter 2024 Financial Results and Provides Business Update
May 9 TARS Tarsus Pharmaceuticals Inc (TARS) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth ...
May 9 TARS Tarsus Pharmaceuticals, Inc. (TARS) Q1 2024 Earnings Call Transcript
May 8 TARS Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Tops Revenue Estimates
May 8 CUTR Cutera Q1 2024 Earnings Preview
May 8 TARS Tarsus Pharmaceuticals GAAP EPS of -$1.01 beats by $0.18, revenue of $27.61M beats by $9.71M
May 8 TARS Tarsus Reports First Quarter 2024 Financial Results and Recent Business Achievements
May 8 ALDX Aldeyra Therapeutics Enrolls First Patient in Phase 3 Clinical Trial Designed to Enable Potential Resubmission of New Drug Application of Reproxalap in Dry Eye Disease
May 7 TARS Tarsus Pharmaceuticals Q1 2024 Earnings Preview
May 6 TARS Does Tarsus Pharmaceuticals (TARS) Have the Potential to Rally 38.7% as Wall Street Analysts Expect?
May 6 VYNE VYNE Therapeutics Announces FDA Clearance of IND Application for VYN202, a Novel BD2-Selective BET Inhibitor
Rosacea

Rosacea is a long-term skin condition that typically affects the face. It results in redness, pimples, swelling, and small and superficial dilated blood vessels. Often the nose, cheeks, forehead, and chin are most involved. A red enlarged nose may occur in severe disease, a condition known as rhinophyma.The cause of rosacea is unknown. Risk factors are believed to include a family history of the condition. Factors that may potentially worsen the condition include heat, exercise, sunlight, cold, spicy food, alcohol, menopause, psychological stress, or steroid cream on the face. Diagnosis is based on symptoms.While not curable, treatment usually improves symptoms. Treatment is typically with metronidazole, doxycycline, or tetracycline. When the eyes are affected azithromycin eye drops may help. Other treatments with tentative benefit include brimonidine cream, ivermectin cream, and isotretinoin. Dermabrasion or laser surgery may also be used. The use of sunscreen is typically recommended.Rosacea affects somewhere between one and ten percent of people. Those affected are most often 30 to 50 years old and female. Caucasians are more frequently affected. The condition was described in The Canterbury Tales in the 1300s, and possibly as early as the 200s BCE by Theocritus.

Browse All Tags